Revenue (TTM) Chart

View Revenue (TTM) for FZMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2023 18.40M
March 31, 2023 18.07M
December 31, 2022 18.64M
September 30, 2022 19.82M
June 30, 2022 19.53M
March 31, 2022 20.53M
December 31, 2021 20.41M
September 30, 2021 21.37M
June 30, 2021 22.86M
March 31, 2021 21.20M
December 31, 2020 21.40M
September 30, 2020 21.72M
June 30, 2020 21.70M
March 31, 2020 22.77M
December 31, 2019 22.90M
September 30, 2019 23.40M
June 30, 2019 24.47M
March 31, 2019 25.11M
December 31, 2018 26.34M
September 30, 2018 44.00M
June 30, 2018 43.23M
March 31, 2018 44.81M
December 31, 2017 44.40M
September 30, 2017 44.15M
June 30, 2017 38.24M
Date Value
March 31, 2017 31.06M
December 31, 2016 25.67M
September 30, 2016 0.9051M
June 30, 2016 1.240M
March 31, 2016 1.607M
December 31, 2015 1.677M
September 30, 2015 1.502M
June 30, 2015 1.266M
March 31, 2015 1.042M
December 31, 2014 0.9411M
September 30, 2014 0.632M
June 30, 2014 0.4249M
March 31, 2014 0.1616M
August 31, 2013 0.00
May 31, 2013 0.00
February 28, 2013 0.00
November 30, 2012 0.00
November 30, 2011 0.00
August 31, 2011 0.00
May 31, 2011 0.00
February 28, 2011 0.00
August 31, 2010 0.00
May 31, 2010
February 28, 2010
November 30, 2009

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Henry Schein, Inc. 13.60B
Accendra Health, Inc. 2.647B
Cencora, Inc. 332.77B
Cardinal Health, Inc. 254.25B
McKesson Corp. 410.98B